Tech Company Financing Transactions

ImmuneBridge Funding Round

Insight Venture Partners, M Ventures and Gaingels participated in a $12 million Seed capital raise for ImmuneBridge. The financing round was recorded on 4/12/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

2122 Bryant St
San Francisco, CA 94110
USA

Phone

Undisclosed

Website

www.immunebridge.com

Email Address

[email protected]

Overview

ImmuneBridge is on a mission to discover and amplify the cures within us. We are a team of scientists and engineers based in the San Francisco Bay Area. We value curiosity, diversity, humility, and generosity--in life and at work. We founded ImmuneBridge in 2018 because we believe cell therapies are the future of medicine and we have a responsibility to make those therapies available to everyone.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Peretz Partensky

        

Chief Scientific Officer

Jesse Cotari

        

Browse more venture capital transactions:

Prev: 4/12/2023: Cognassist venture capital transaction
Next: 4/12/2023: Kala venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary